2-[2-(Morpholin-4-yl)ethyl]-4-nitro-2,3-dihydro-1H-isoindol-1-one

Catalog No. :
ACEPMA060
CAS No. :
900019-24-1
Molecular Formula :
C14H17N3O4
Molecular Weight :
291.31

IUPAC Name:2-(2-morpholinoethyl)-4-nitroisoindolin-1-one

2-[2-(Morpholin-4-yl)ethyl]-4-nitro-2,3-dihydro-1H-isoindol-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$580.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[2-(Morpholin-4-yl)ethyl]-4-nitro-2,3-dihydro-1H-isoindol-1-one
IUPAC Name2-(2-morpholinoethyl)-4-nitroisoindolin-1-one
MDL No.MFCD07021465
Molecular FormulaC14H17N3O4
Molecular Weight291.31
SMILESO=C1N(CCN2CCOCC2)CC3=C1C=CC=C3[N+]([O-])=O
InChI KeyKSSSHFXTTGDJNM-UHFFFAOYSA-N
Synonym2-(2-MORPHOLINOETHYL)-4-NITRO-1-ISOINDOLINONE;2-[2-(morpholin-4-yl)ethyl]-4-nitro-2,3-dihydro-1H-isoindol-1-one;1H-Isoindol-1-one, 2,3-dihydro-2-[2-(4-morpholinyl)ethyl]-4-nitro-;2-(2-Morpholinoethyl)-4-nitroisoindolin-1-one
CAS No.900019-24-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEPMA060 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEPMA060 route product structure diagram
    ACEPMA060900019-24-1
Inquiry

2. ACEPMA060 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKDJY654 route compound structure diagram
    ACKDJY654366452-97-3 In Stock
  4. Then
  5. ACEPMA060 route product structure diagram
    ACEPMA060900019-24-1
Inquiry

Comments (0)